他汀类药物防治帕金森病的临床效果及作用机制研究进展

被引：2

作者：

祁敏 ^{[1
]}

魏显招 ^{[2
]}

姜秀峰 ^{[3
]}

机构：

[1] 第二军医大学长征临床医学院

[2] 第二军医大学长海临床医学院

[3] 第二军医大学长海医院神经外科

来源：

第二军医大学学报 | 2011年 / 32卷 / 01期

关键词：

他汀类药物; 帕金森病; 预防; 治疗;

D O I：

暂无

中图分类号：

R742.5 [震颤麻痹综合征];

学科分类号：

1002 ;

摘要：

他汀类药物是一类降血脂药,它们是羟甲基戊二酸单酰辅酶A还原酶的抑制剂。他汀类药物具有多效性,最近的研究表明其可能具有防治帕金森病的潜力。本文就近年来他汀类药物在防治帕金森病的临床效果及作用机制方面的研究进展作一综述。

引用

页码：92 / 95

页数：4

共 13 条

[1] Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease [J].

Mutez, Eugenie ;

Duhamel, Alain ;

Defebvre, Luc ;

Bordet, Regis ;

Destee, Alain ;

Kreisler, Alexandre .

PHARMACOLOGICAL RESEARCH, 2009, 60 (01) :41-45

[2]

Zocor Forte? （simvastatin） has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP + does not[J] . Marti Santiago,Mari Carmen Hernández-Romero,Alberto Machado,Josefina Cano.European Journal of Pharmacology . 2009 (1)

[3]

Statin use and the risk of Parkinson disease: a nested case control study[J] . Ali Samii,Bruce C. Carleton,Mahyar Etminan.Journal of Clinical Neuroscience . 2008 (11)

[4]

Statin use and the risk of Parkinson disease[J] . Angelika D. Wahner,Jeff M. Bronstein,Yvette M. Bordelon,Beate Ritz.Neurology . 2008 (16,)

[5]

Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences[J] . Katrin Beyer,Aurelio Ariza.Journal of Neuropathology and Experimental Neurology . 2007 (11)

[6]

Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes[J] . Brain Research . 2006 (1)

[7] Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity [J].

Liao, PC ;

Kuo, YM ;

Hsu, HC ;

Cherng, CG ;

Yu, L .

JOURNAL OF NEUROCHEMISTRY, 2005, 95 (01) :160-168

[8]

Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice[J] . Michael L. Selley.Brain Research . 2005 (1)

[9] Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice [J].

Chen, JL ;

Zhang, CL ;

Jiang, H ;

Li, Y ;

Zhang, LJ ;

Robin, A ;

Katakowski, M ;

Lu, M ;

Chopp, M .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (02) :281-290

[10] Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration [J].

Arimoto, T ;

Bing, GY .

NEUROBIOLOGY OF DISEASE, 2003, 12 (01) :35-45

← 1 2 →